Novel drug targets for asthma and COPD: Lessons learned from in vitro and in vivo models

Keyphrases

• Airway Hyperresponsiveness 33%
• Airway Inflammation 33%
• Airway Obstruction 33%
• Asthma 100%
• Asthma Treatment 33%
• Chronic Obstructive Pulmonary Disease 100%
• Current Therapies 33%
• Disease Progression 33%
• In Vivo Model 100%
• Kinase Inhibitor 33%
• Lessons Learned 100%
• New Drug Targets 33%
• Novel Therapeutic Targets 100%
• Phosphodiesterase Inhibitors 33%
• Protease Inhibitors 33%
• Respiratory Disease 33%
• TRP Channels 33%
• Vitamin D 33%
• β-agonists 33%

Pharmacology, Toxicology and Pharmaceutical Science

• Airway Obstruction 33%
• Anti-Inflammatory Drug 33%
• Asthma 100%
• Beta Adrenergic Receptor Stimulating Agent 33%
• Chronic Obstructive Lung Disease 100%
• Disease Exacerbation 33%
• Glucocorticoid 33%
• Phosphodiesterase Inhibitor 33%
• Phosphotransferase Inhibitor 33%
• Proteinase Inhibitor 33%
• Respiratory Tract Allergy 33%
• Respiratory Tract Disease 33%
• Respiratory Tract Inflammation 33%
• Symptom 33%
• Transient Receptor Potential Channel 33%
• Vitamin D 33%